Regeneron Rheumatoid Arthritis Drug Meets Goal
NEW YORK (AP) — Regeneron Pharmaceuticals Inc. and Sanofi said a clinical trial showed their drug candidate sarilumab reduced symptoms of moderate to severe rheumatoid arthritis. The companies said...
View ArticleFDA Panel Unanimously Favors Accelerated Approval for Seattle Genetics' Drug
A panel of federal cancer experts has unanimously voted to grant accelerated approval to Seattle Genetics' (Nasdaq:SGEN) innovative chemotherapy drug to treat patients with recurring Hodgkin's disease,...
View ArticleAuxilium Pharmaceuticals, FCB I LLC Sue Watson for Infringement of Testim...
The pharma firms allege that Watson is violating numerous patents with its proposed generic version of the testosterone gel. Auxilium Pharmaceuticals, Inc. and FCB I LLC announced today that they...
View Article
More Pages to Explore .....
